Erratum: Notch1 in primary effusion lymphoma: A clinicopathological study (Modern Pathology (2010) 23 (773-780) DOI: 10.1038/modpathol.2010.67);Notch1 in primary effusion lymphoma: A clinicopathological study

Modern Pathology

Volumn 23, Issue 6, 2010, Pages 773-780

  Wang, Huan You ^a   Fuda, Franklin S ^a   Chen, Weina ^a   Karandikar, Nitin J ^a  

^a Department of Pathology ^*  (United States)

Author keywords

Human herpes virus 8; Notch1; Primary effusion lymphoma

Indexed keywords

ASBESTOS; CD30 ANTIGEN; CD38 ANTIGEN; CD45RO ANTIGEN; CD71 ANTIGEN; HLA DR ANTIGEN; NOTCH1 RECEPTOR; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CELL STRUCTURE; CLINICAL ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; FLOW CYTOMETRY; GERIATRIC PATIENT; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEPATITIS C; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77953135790     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.79     Document Type: Erratum

References (28)

1. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-1191.
2. Knowles DM, Inghirami G, Ubriaco A, et al. Molecular genetic analysis of three AIDS-associated neoplasm sod uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 1989;73:792-799.
3. Cobo F, Hernandez S, Hernandez L, et al. Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient. J Pathol 1999;189:288-293.
4. Nicholas J. Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia. Front Biosci 2007;12:265-281.
5. Chang H, Dittmer DP, Chul SY, et al. Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 2005;79: 14371-14382. (Pubitemid 41552734)
6. Lan K, Murakami M, Choudhuri T, et al. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency. Virol 2006;351:393-403.
7. Lan K, Choudhuri T, Murakami M, et al. Intracellulart activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus- associated B-lympho-ma cell lines in vitro. J Virol 2006;80:6411-6419.
8. Wilson KS, McKenna RW, Kroft SH, et al. Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities. Br J Haematol 2002;116: 113-121.
9. Said J, Cesarman E. Primary Effusion Lymphoma in WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Vardiman JW (eds), IARC: Lyon, 2008, pp 260-261.
10. Kroft SH, Asplund SL, McKenna RW, et al. Haemato-gones in the peripheral blood of adults: a four-color flow cytometry study of 102 patients. Br J Haematol 2004;126:209-212.
11. Lukac DM, Renne R, Kirshner JR, et al. Reactivation of Kaposi'a sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transacti-vator, a homolou of the EBV R protein. Virol 1998;252:304-312.
12. Noguchi K, Fukazawa H, Murakami Y, et al. Gamma-herperviruses and cellular signaling in AIDS-associated malignancies. Cancer Sci 2007;98:1288-1296.
13. Kovall RA, Herdrickson WA. Crystal structure of the nuclear effector of Notch signaling, CSL, bound to DNA. EMBO J 2004;23:3441-3451.
14. Rao SS, O'Neil J, Liberator CD, et al. Inhibition of NOTCH signaling by gamma secretatse inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia. Cancer Res 2009;69:3060-3068.
15. Pui CH. T cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcome. Cancer Cell 2009;15:85-87.
16. Lubyova B, Kellum MJ, Frisancho JA, et al. Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirus. J Biol Chem 2007;282:31944-31953.
17. Bubman D, Guasparri I, Cesarman E. Deregulation of c-Myc in primary effusion lymphoma by Kaposi sarcoma herpesvirus latency-associated nuclear antigen. Oncogene 2007;26:4979-4986.
18. Keller SA, Schattner EJ, Cesarman E. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 2000;96:2537-2542.
19. Brown HJ, Song MJ, Deng H, et al. NF-kB inhibits gammaherpesvirus lytic replication. J Virol 2003;77: 8532-8540.
20. Ye FC, Zhou FC, Xie JP, et al. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency. J Virol 2008;82:4235-4249.
21. Boulanger E, Agbalika F, Maarek O, et al. A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. Hematol J 2001;2: 172-179. (Pubitemid 32633668)
22. Boulanger E, Marchio A, Hong SS, et al. Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/b-catenin genes in human herpesvirus 8-associated primary effusion lymphoma. Haematologica 2009;94:1170-1174.
23. Boulannger E, Hermine O, Fermand JP, et al. Human herpesvirus 8 (HHV-8)-associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patients. Am J Haematol 2004;76:88-91.
24. Kishimoto K, Kitamuyra T, Hirayama Y, et al. Cytologic and immunocytochemical features of EBV negative primary effusion lymphoma: report on seven Japanese cases. Diagn Cytopathol 2009;37:293-298.
25. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinical entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-656.
26. Tsagarakis NJ, Argyrou A, Gortzolidis G, et al. Report of an HIV amnd HHV-8 negative case of primary effusion lymphoma with idiopathic T4 lymphocyto-penia. Int J Haematol 2009;90:94-98.
27. Matsumoto Y, Nomura K, Ueda K, et al. Human herpesvirus-8-negative primary effusion lymphoma: a distinct clinical entity and successful treatment with rituximab. Leuk Lymphoma 2005;46:415-419.
28. Paner GP, Jensen J, Foreman KE, et al. HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. Leuk Lympho-ma 2003;44:1811-1814.